Do they know something that we do not — HHS

| No Comments

From the U.S. Department of Health & Human Services,  Administration for Strategic Preparedness and Response
Press Release dated October 4th, 2022

HHS purchases drug for use in radiological and nuclear emergencies
As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

No mention of how many doses but the budget is $290 million...
This is under a program started in 2004 so nothing new but why now?  Why $290M worth?

Leave a comment

March 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

About this Entry

This page contains a single entry by DaveH published on October 5, 2022 7:02 PM.

Finally, we know the real reason was the previous entry in this blog.

And that is it for tonight is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Monthly Archives


OpenID accepted here Learn more about OpenID
Powered by Movable Type 5.2.9